I111 Pill - yellow capsule/oblong, 16mm
Pill with imprint I111 is Yellow, Capsule/Oblong and has been identified as Minocycline Hydrochloride Extended Release 135 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Minocycline is used in the treatment of Acne; Bacterial Infection; Bartonellosis; Actinomycosis; Bullous Pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for I111
Minocycline Hydrochloride Extended Release
- Imprint
- I111
- Strength
- 135 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00781-5387
- Inactive Ingredients
-
silicon dioxide,
lactose monohydrate,
magnesium stearate,
titanium dioxide,
triacetin,
ferric oxide yellow,
hypromellose 2208 (15000 mPa.s),
hypromellose 2910 (15 mPa.s)
Note: Inactive ingredients may vary.
Related images for "I111"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (562)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline (Oral) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Dynacin, Solodyn, Minolira, ... +2 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Solodyn, Minocin for Injection, Minolira, Ximino
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
